http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2688235-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34fa08f37a5571d671371ce3effab321 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate | 2018-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_506ae7a89eb7841d1e144456a3ff38bb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_500cbf4f92f344490f9c29fff7d95233 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b55a71c51ae16f382dc8a6347713903 |
| publicationDate | 2019-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2688235-C1 |
| titleOfInvention | Pharmaceutical anti-diabetic composition based on substituted thiophene carboxylate and a method for production thereof |
| abstract | FIELD: medicine; pharmaceuticals. n SUBSTANCE: group of inventions refers to medicine, chemical-pharmaceutical industry and pharmacy, more specifically to a pharmaceutical composition for oral administration, having hypoglycemic and hypolipidemic activity. Pharmaceutical composition contains (Z)-ethyl 2-(4-(4-chlorophenyl)-2,4-dioxo-3-(3-oxo-3,4-dihydroquinoxalin-2(1H)-ylidene)butanamido)-4-methyl-5-phenylthiophene-3-carboxylate as an active substance and additives –microcrystalline cellulose, sodium croscarmellose, crospovidone, lactose monohydrate, partially pregelatinized corn starch, stearic acid salt. Pharmaceutical composition is presented in the form of a tablet coated with a coating. Second invention relates to a method for preparing a pharmaceutical composition which consists in using wet granulation and direct pressing of various components. n EFFECT: group of inventions is characterized by sufficient mechanical strength, high therapeutic activity, satisfactory technological characteristics and stable during storage for at least 2 years. n 12 cl, 1 tbl, 3 ex |
| priorityDate | 2018-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 128.